Recruiting NCT05480644
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Brain Tumor, Primary, Brain Metastases, Adult. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Detailed description
Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.
Primary outcome measures
- Number of circulating immune cells in peripheral blood [Time frame: 6 weeks post radiation therapy]
Eligibility criteria
Inclusion criteria
- Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)
Exclusion criteria
- None
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- Duke Cancer Center — Durham
Identifiers
NCT: NCT05480644 · Pro00110602